Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

New program aims to keep seniors strong and independent longer

NCT ID NCT06280586

Prevention Sponsor: Consorci Sanitari del Maresme Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 2 times

Summary

This study tested a program that combines diet advice, exercise, medication review, and social support to prevent frailty in older adults who are at risk. 232 people aged 70 and older took part. The goal was to see if this approach could help them stay stronger and more independent.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
multidisciplinary program (diet, exercise, medication review, social support)
What this could lead to
If successful, this program could offer a practical way to prevent frailty and help older adults maintain strength and independence.
What could go wrong
This is a completed trial with 232 participants, but the intervention is complex and may be hard to replicate widely. Results may not apply to all older adults.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

232 people

The number who actually took part.

Started

Nov 2021

Finished

Dec 2024

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

70 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Men or women 70 years of age or older at the time of recruitment * That they meet pre-frail phenotype criteria according to L. Fried's criteria * That they give their written informed consent to participate in the study. Exclusion Criteria: * Severe dementia (GDS\>3) * Other neurodegenerative diseases (Parkinson's disease) * Neuromuscular diseases * Serious psychiatric illness that, at the doctor's discretion, prevents good compliance with the study intervention * Active cancer * Life expectancy of less than 6 months * Institutionalized patient * Unstable ischemic heart disease, uncontrolled arrhythmias, dissecting aortic aneurysm, severe aortic stenosis, uncontrolled arterial hypertension (\>180/100mmHg), or severe heart failure. * Acute diseases or acute or poorly controlled chronic diseases * Bone fractures in the last 3 months.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Frailty are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

Frailty Sarcopenia

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Frailty Muscle strengh Sarcopenia

Contacts and locations

Locations

  • Consorci Sanitari del Maresme

    Mataró, Barcelona, 08304, Spain

  • Mateu Serra-Prat

    Mataró, Barcelona, 08304, Spain

More trials for these conditions

Other studies related to the condition(s) this trial covers.